ArticleEndocrine connections2022

Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors.

Kazhan Mollazadegan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.